In the past, it was believed that LSD1 played a role in prostate cancer by regulating the transcriptional activity of AR, because LSD1 can remove the methylation of the transcriptional repressive marker H3K9me1/2 (18–20). The gene discussed is KDM1A; the disease is prostate carcinoma.